Skip to content

Health · AU · 03:43

MDT-BRIDGE: Early ctDNA Clearance Predicts Pathological Response and Favorable Outcomes in Stage II–III NSCLC

Oncodaily · Health

Published 27 Oct 2026, 03:43 AEDT

MDT-BRIDGE: Early ctDNA Clearance Predicts Pathological Response and Favorable Outcomes in Stage II–III NSCLC

Read it at the source

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now

Health · 03:407 Surprising Benefits of GLP-1s Beyond Blood SugarMaking Sense of Diabetes · HealthMaking Sense of Diabetes↗

Health · 04:30Additional education protects people with high genetic risk of dementiaNews-Medical · HealthNews-Medical↗

Games · 13:03Mass Effect Shepard Actors, Destiny Community Join SaveMassEffect Movement and PetitionIGN · GamesIGN↗

News · 11:28Sligar overjoyed for home World CupThe Age · NewsThe Age↗

News · 09:13‘Outrageous’: Payman asks if PM is waiting for attack on her in bitter staff feudSMH.com.au · NewsSMH.com.au↗

Politics · 11:24Duress alarms for MPs under consideration, PM tells caucusThe Australian Financial Review · PoliticsThe Australian Financial Review↗

World · 10:15Australia in South Africa: Cooper Connolly set to play for Aussies in deciding Testthenightly.com.au · Worldthenightly.com.au↗

Business · 11:24Megaport, NextDC no shows at Canaccord’s tech conferenceThe Australian Financial Review · BusinessThe Australian Financial Review↗

120sec · About · Editorial · Corrections · Contact · Privacy · Cookies